Orsolya Csuka

A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity.

G Kéri, J. Érchegyi, Anikó Horváth et al. · Proceedings of the National Academy of Sciences · 1996 · 97 citations

Tumor Biology, Oncology, Tumor-selective Somatostatin Analog +14

In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells.

Nóra Gyémánt, Masaru Tanaka, Sándor Antus et al. · PubMed · 2005 · 51 citations

Chemoprevention Strategy, Biochemistry, Medicine +15

Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis

Károly Fazekas, Orsolya Csuka, István Köves et al. · Clinical & Experimental Metastasis · 2000 · 45 citations

Novel Somatostatin Analogs with Tyrosine Kinase Inhibitory and Antitumor Activity

Gÿorgý Kéri, Imre Mező, Anikó Horváth et al. · Biochemical and Biophysical Research Communications · 1993 · 37 citations

Medicinal Chemistry, Medicine, Receptor Tyrosine Kinase +8

Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors.

Judit Olasz, László Mándoky, Lajos Géczi et al. · PubMed · 2006 · 34 citations